“It is a big blow for us. Ellis is a crucial bowler, especially in the death overs. We are looking at replacements,” said Kasi Viswanathan, CEO of Chennai Super Kings (CSK), following the announcement that Nathan Ellis would miss IPL 2026 due to a hamstring injury.
Ellis, who is 31 years old, was anticipated to play a pivotal role as CSK’s primary death over specialist in the upcoming tournament. His absence creates a significant challenge for the franchise, which is already under pressure after finishing at the bottom of the points table in IPL 2025, winning only 4 out of 14 matches.
CSK’s struggles in the previous season were compounded by the release of Matheesha Pathirana, who had been relied upon as a death over weapon since 2022. With Ellis sidelined, the team is now actively searching for a suitable replacement to fill the void left by the Australian bowler.
Ellis was also part of Australia’s T20 World Cup squad prior to his injury, highlighting his importance in the international arena. His performance in the IPL was expected to bolster CSK’s bowling attack, particularly in the crucial final overs of matches.
As the team gears up for their opening game against Rajasthan Royals on March 30, the urgency to find a replacement has intensified. With only 9 days remaining until the match, the clock is ticking for CSK to finalize their plans.
Viswanathan’s remarks underscore the gravity of the situation, as the franchise must quickly adapt to the loss of a key player. The upcoming season is critical for CSK, who are looking to rebound from their disappointing previous campaign.
Details remain unconfirmed regarding potential candidates to replace Ellis, but the franchise’s management is expected to explore various options in the coming days. The impact of this injury could resonate throughout the tournament as CSK seeks to regain its competitive edge.
With the IPL 2026 season fast approaching, all eyes will be on how CSK navigates this setback and whether they can find a suitable replacement for Nathan Ellis in time.